<DOC>
	<DOCNO>NCT00939887</DOCNO>
	<brief_summary>This subject blind , investigator sponsor open , randomize study consist 2 part . Up 15 healthy subject include study . In first part study test retest reliability radiotracer [ 11C ] PF 04767135 bind man assess . In second part study , use [ 11C ] PF 04767135 , kappa opioid receptor occupancy ( RO ) assess three cohort subject .</brief_summary>
	<brief_title>A Study Of Kappa Opioid Receptor Occupancy Of PF-04455242 , Using PET ( Positron Emission Tomography )</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Healthy male and/or female subject nonchildbearing potential age 18 55 year , inclusive . ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12 lead ECG clinical laboratory test . ) Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Any condition possibly affect drug absorption ( eg , gastrectomy ) . A positive urine drug screen Screening Day 0 . History regular alcohol consumption exceed 7 drinks/week female 14 drinks/week men . Use tobacco nicotinecontaining product within 3 month screen . Treatment investigational drug within 30 day 5 half life precede first dose study medication ( exclude [ 11C ] PF 04767135 ) . 12 lead ECG demonstrate QTc &gt; 450 msec Screening . Pregnant nursing female ; female childbearing potential .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>